GH
Guardant Health, Inc.
Guardant Health is a precision oncology diagnostics company whose revenue and growth hinge on Medicare reimbursement rates, FDA oversight of lab-developed tests, and legislation expanding cancer-screening coverage.
Govt Dependence
55/100
Regulatory Density
72/100
Lobbying Intensity
25/100
Political Signal
MEDIUM
BusinessWhat GH does
Guardant Health develops blood-based (liquid biopsy) genomic tests for cancer detection, treatment selection, and recurrence monitoring, including Guardant360 and Shield. Revenue is driven by clinical test volumes reimbursed largely through Medicare and private payers, plus biopharma development services.
12 months past · 3 months futureGH activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
250 trading days ·
1 congressional trades shown
·
0 insider buys
·
12 13F filings
·
0 past bill actions
·
3 upcoming markups
Lifetime Government AwardsGH federal contracts by year
$14K
total awarded · 2017–2021
2
contracts on file
2021
peak year ($14K)
Top contracts by award amount
$14K
Department of Health and Human Serv
2021-09-20
LABORATORY TESTING
$0K
Department of Veterans Affairs
2017-07-05
IGF::OT::IGF - EMERGENCY GENETIC TESTING FOR PATIENT DIAGNOSIS
5 years · 2 contracts
Smart Money · 13F HoldingsHedge funds holding GH
$422.11B
Total GH held by tracked 13F funds
9
Funds with GH positions
+1
Funds opened this quarter
Two Sigma Investments
$390.68B
+95%
2026-03-31
Renaissance Technologies
$31.18B
-44%
2026-03-31
D.E. Shaw & Co.
$95M
+266353%
1 overlap
2025-12-31
D.E. Shaw & Co.
$57M
-99%
1 overlap
2025-12-31
Citadel Advisors
$40M
+333%
1 overlap
2025-12-31
Citadel Advisors
$39M
-98%
1 overlap
2025-12-31
D.E. Shaw & Co.
$10M
+835%
1 overlap
2025-12-31
Bridgewater Associates
$3M
+606%
1 overlap
2025-12-31
1 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading GHMembers of Congress with recent GH positions
1 politicians traded GH across 1 disclosed transactions totaling $8K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just GH). 0-30 LOW · 30-60 MID · 60+ HIGH.
Congressional TradesWho in Congress is trading GH
2025-11-21
Sheldon Whitehouse
Purchase
$1,001 - $15,000
2022-02-28
Donald S. Beyer
Sale
$1,001 - $15,000
2022-02-28
Donald S. Beyer
sale
$1,001 - $15,000
2022-01-13
Donald S. Beyer
Sale
$1,001 - $15,000
2022-01-13
Donald S. Beyer
sale
$1,001 - $15,000
2021-12-22
Donald S. Beyer
sale
$1,001 - $15,000
2021-12-22
Donald S. Beyer
Sale
$1,001 - $15,000
2020-11-02
Donald S. Beyer
Purchase
$1,001 - $15,000
2020-11-02
Donald S. Beyer
purchase
$1,001 - $15,000
2020-10-05
Donald S. Beyer
purchase
$1,001 - $15,000
2020-10-22
Donald S. Beyer
purchase
$1,001 - $15,000
2020-10-05
Donald S. Beyer
Purchase
$1,001 - $15,000
21+ trades on file · most recent 2025-12-01
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
10
option exercises · $219K
For GH, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting GHLive legislation impacting this stock
HR.1875 · 119th
Medicaid Provider Screening Accountability Act
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HR.1806 · 119th
Triple-Negative Breast Cancer Research and Education Act of 2025
S.786 · 119th
Public Health Funding Restoration Act
HR.920 · 119th
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
HR.679 · 119th
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strate
S.708 · 118th
A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
S.574 · 118th
Increasing Prescription Drug Competition Act
S.669 · 118th
Increasing Mental Health Options Act of 2023
SRES.90 · 118th
A resolution recognizing the significance of endometriosis as an unmet chronic disease for women and designating March 2023 as "En
Political ProfileWhere GH sits in Washington
nonpartisan
Shares react to CMS reimbursement decisions, Medicare MCED coverage legislation, and FDA LDT rulemaking, though clinical/trial data and volume trends are the dominant drivers.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA final rule regulating lab-developed tests (LDTs)
- CMS reimbursement rate cuts (PAMA/CLFS)
- Medicare local coverage determination reversals
- drug/diagnostic price pressure
Regulatory opportunities
- Medicare coverage for multi-cancer early detection (MCED) screening
- favorable CMS reimbursement expansion
- broadened Medicare screening benefits
LobbyingWho's hired to advocate for GH
American Clinical Laboratory Association (ACLA)AdvaMedPersonalized Medicine Coalition
Member intelligence layer
Live signals + predictions for GH — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades GH
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout GH & political exposure
Does Guardant Health, Inc. (GH) hold federal contracts?
Yes. Guardant Health, Inc. has 2 federal contract awards totaling $14,000, primarily from agencies including Department of Health and Human Services, Department of Veterans Affairs. See full contract list and amounts on this page.
Has Congress traded GH stock?
21 congressional trades by 2 unique members of Congress, most recently on 2025-11-21. See the Congressional Trading panel for politician-by-politician breakdown.
What is GH political risk profile?
Government dependence: 55/100. Lobbying intensity: 25/100. Political signal: medium. Donor party split: nonpartisan.
How does GovGreed track GH political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. GH data is updated daily from these official federal sources.